Senate unanimously passes resolution to designate May as ALS Awareness Month

Source: United States Senator for Delaware Christopher Coons

WASHINGTON – This week, the Senate unanimously passed a resolution introduced by Senators Chris Coons (D-Del.), Tom Cotton (R-Ark.), Sheldon Whitehouse (D-R.I.), Mike Braun (R-Ind.), to designate May 2022 as ALS Awareness Month. Text of the resolution may be found here.

“ALS is a cruel disease that takes the lives of thousands of Americans every year, and we must work together by sustaining research and expanding treatment and therapy options. That’s why I worked so hard to secure passage of my bipartisan ACT for ALS bill, which President Biden signed into law last year, and continue to work with my colleagues to secure full funding for that law today,” said Coons. “I hope that with more awareness around ALS, we will be able to better support patients and their loved ones while we continue to ceaselessly search for a cure.”

“Each year, thousands of Americans are diagnosed with ALS—a progressive and disabling disease for which there is no cure. I’m proud to work with my colleagues to raise awareness about ALS and help bring relief to Americans living with the disease,” said Cotton.

“It takes tremendous courage from patients, families, and friends to cope with an ALS diagnosis – a relentless and debilitating disease,” said Whitehouse.  “It’s my hope that by passing this ALS Awareness Month resolution, we will draw attention to those affected by ALS and the researchers working on new treatments on the path to a cure.”

“There is no ALS survivor community, so it’s a top priority for me to advocate in Congress for those that are diagnosed with this devastating disease. As a co-founder of the first Senate ALS Caucus with Senator Coons, I am proud to join my Senate colleagues in designating May as ALS Awareness Month,” said Braun.

Senator Coons is a strong advocate for ALS patients and access to treatment. His bipartisan legislation, the ACT for ALS Act, funds essential research into rare, neurodegenerative illnesses such as ALS, and was signed into law by President Biden late last year.

 

###